Document is current
Any future updates will be listed below
-
Authors
Soliman, Hatem
Aldrich, Amy
Abdo, Neveen
Han, Hyo https://orcid.org/0000-0002-0072-0257
Soyano, Aixa
Costa, Ricardo https://orcid.org/0000-0002-3303-3234
Armaghani, Avan
Kiluk, John https://orcid.org/0000-0001-5889-2441
Khakpour, Nazanin
Lee, Marie Catherine
Hoover, Susan
Laronga, Christine
Niell, Bethany https://orcid.org/0000-0003-0350-7942
Mooney, Blaise
Weinfurtner, Robert Jared
Rosa, Marilin
Czerniecki, Brian
-
Funding
Funding for this research was provided by:
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385, W81XWH-16-1-0385)
- License Information
-
More Information
Article History
Received: 18 June 2024
Accepted: 3 March 2025
First Online: 17 March 2025
Competing interests
: HS has consulted for: Eli Lilly, Astrazeneca, Novartis, PUMA, Pfizer, Sermonix. BN has research support from Hologic. RC has consulted for: Pfizer, Gilead, Daiichi Sankyo and Astra Zeneca Speaker’s Bureau for: Pfizer, Daiichi Sankyo, and Astra Zeneca Honoraria from: Pfizer, Athenex Oncology, Daiichi Sankyo and Astra Zeneca. HH received institutional research funding from: Arvinas, Abbvie, Pfizer, Zymeworks, Quantum Leap Health, Senwha, Mersana, Gilead Advisory Board: Paradigm, Pfizer. BC has intellectual property rights/licensure for DC1 vaccine from Immunorestoration. The remaining authors have not declared relevant COI.
